Propanc Biopharma Inc (PPCB)

[Babubd]

Loading zone. She is insanely undervalued. Wait and enjoy the ride. $PPCB

Propanc Biopharma climbed $0.28+ commencing $0.003 per share in less than a week in 2018. We may see a same type of run in 2020. Wait and enjoy the ride. $PPCB

Flippers and shorts are gonna be scrambling, weeping and biting their nails.

3-month high was $0.0074 per share, 6-month high was $0.06 per share and 1-yr high was $1.75 per share..just beautiful.

The number of share outstanding is only 688.67 million.

https://www.otcmarkets.com/stock/PPCB/security

Know What You Own

Propanc Biopharma, Inc. (the “Company”) is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from pancreatic, ovarian and colorectal cancers. For more information, please visit www.propanc.com.

The Company’s novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body’s primary defense against cancer.

To view the Company’s “Mechanism of Action” video on its anti-cancer lead product candidate, PRP, please click on the following link: www.propanc.com/news-media/video

https://ca.finance.yahoo.com/quote/PPCB?p=PPCB&.tsrc=fin-srch

Propanc Biopharma Receives Investment from Institutional Investor

https://ca.finance.yahoo.com/news/propanc-biopharma-receives-investment-institutional-123000286.html

How Propanc Biopharma Is Joining the Fight with Cancer Patients Who Are Increasingly Vulnerable to the COVID-19 Global Pandemic

https://ca.finance.yahoo.com/news/propanc-biopharma-joining-fight-cancer-123000494.html